Functional imaging in penile cancer: PET/computed tomography, MRI, and sentinel lymph node biopsy

Current Opinion in Urology

Volumn 18, Issue 1, 2008, Pages 105-110

  Mueller Lisse, Ullrich G ^a   Scher, Bernhard ^a   Scherr, Michael K ^a   Seitz, Michael ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Lymph node metastasis; Magnetic resonance imaging; Penile cancer; Positron emission tomography; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; NANOPARTICLE;

ABDOMEN; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; INGUINAL LYMPH NODE; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PENIS CANCER; PHYSICAL EXAMINATION; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

DIAGNOSTIC IMAGING; HUMANS; LYMPHATIC METASTASIS; MALE; NANOPARTICLES; NEOPLASM STAGING; PENILE NEOPLASMS; PHYSICAL EXAMINATION; SENTINEL LYMPH NODE BIOPSY;

EID: 37349024253     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f151fd     Document Type: Review

References (29)

1. Solsona E, Algaba F, Horenblas S, et al. European Association of Urology. EAU Guidelines on Penile Cancer. Eur Urol 2004; 46:1-8.
2. Micali G, Nasca MR, Innocenzi D, Schwartz RA. Invasive penile carcinoma: a review. Dermatol Surg 2004; 30:311-320.
3. American Cancer Society. Cancer facts and figures 2007. Atlanta: American Cancer Society; 2007. This provides current statistics and projections for development of incidence and mortality of penile cancer.
4. Pow-Sang MR, Benavente V, Pow-Sang JE, et al. Cancer of the penis. Cancer Control 2002; 9:305-314.
5. Schoen EJ, Oehrli M, Colby C, Machin G. The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 2000; 105:E36.
6. Singh AK, Saokar A, Hahn PF, Harisinghani MG. Imaging of penile neoplasms. Radiographics 2005; 25:1629-1638.
7. Lont AP, Besnard AP, Gallee MP, et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 2003; 6:493-495.
8. Kayes O, Minhas S, Allen C, et al. The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 2007; 51:1313-1319. This paper provides respective sensitivity and specificity of MRI in staging primary penile cancer, separately for TNM 2002 classifications T1, T2, and T3, in a large series of 55 patients from one institution.
9. Scher B, Seitz M, Reiser M, et al. 18F-FDG PET/CT for staging of penile cancer. J Nucl Med 2005; 9:1460-1465.
10. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004; 4:240-247.
11. Rippentrop JM, Joslyn SA, Konty BR. Squamous cell carcinoma of the penis: evaluation of data from the Surveillance, Epidemiology, and End Results program. Cancer 2004; 101:1357-1363.
12. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int 2001; 5:473-483.
13. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 1993; 72:817-819.
14. Algaba F, Horenblas S, Pizzocaro-Luigi Piva G, et al. EAU guidelines on penile cancer. Eur Urol 2002; 3:199-203.
15. Hungerhuber E, Schlenker B, Karl A, et al. Risk stratification in penile carcinoma: 25-year experience with surgical inguinal lymph node staging. Urology 2006; 68:621-625. The authors demonstrate the importance of risk stratification by T-staging and grading of primary penile cancer for assessment of presence or absence of lymph node metastasis.
16. Borchers H, Jakse G. Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit. Urologe A 2005; 44:657-661.
17. Tabatabaei S, Harisinghani M, McDougal WS. Regional lymph node staging using lymphotrophic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol 2005; 174:923-927.
18. Izawa J, Kedar D, Wong F, Pettaway CA. Sentinel lymph node biopsy in penile cancer: evolution and insights. Can J Urol 2005; 12 (Suppl 1):24-29.
19. Ravi R. Morbidity following groin dissection for penile carcinoma. Br J Urol 1993; 72:941-945.
20. Kroon BK, Horenblas S, Meinhardt W, et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 2005; 47:601-606.
21. Chen MF, Chen WC, Wu CT, et al. Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan. World J Urol 2004; 22:60-66.
22. Derakhshani P, Neubauer S, Braun M, et al. Results and 10-year follow-up in patients with squamous cell carcinoma of the penis. Urol Int 1999; 62:238-244.
23. Kroon BK, Horenblas S. Re: Regional lymph node staging using lymphotrophic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol 2006; 175:1174.
24. Tanis PJ, Lont AP, Meinhardt W, et al. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 2002; 168:76-80.
25. Leijte JA, Kroon BK, Valdés Olmos RA, et al. Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol 2007; 52:170-177. This paper demonstrates by comparison of a historical cohort of 157 explored groins with a contemporary cohort of 105 that modifications to the technique of dynamic sentinel lymph node biopsy (SLNB) are associated with a decrease of false-negative inguinal lymph node biopsies from 19.2% to 4.8% in patients with penile cancer.
26. Stattaus J, Bockisch A, Forsting M, Müller SP. Value of imaging for lymph node metastasis from renal cell, bladder, prostate, penile, and testicular cancers. Urologe A 2005; 44:614-624.
27. Langen KJ, Borner AR, Muller-Mattheis V, et al. Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors. J Nucl Med 2001; 5:752-754.
28. Ravizzini GC, Wagner M, Borges-Neto S. Positron emission tomography detection of metastatic penile squamous cell carcinoma. J Urol 2001; 5: 1633-1634.
29. Joerger M, Warzinek T, Klaeser B, et al. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004; 63:778-780.